Page last updated: 2024-11-06

lysergic acid diethylamide and Cerebral Infarction

lysergic acid diethylamide has been researched along with Cerebral Infarction in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DALESSIO, DJ1

Other Studies

1 other study available for lysergic acid diethylamide and Cerebral Infarction

ArticleYear
CENTRAL MECHANISMS IN HEADACHE.
    Headache, 1965, Volume: 5

    Topics: Brain; Brain Ischemia; Cerebral Infarction; Drug Therapy; Headache; Humans; Ischemic Attack, Transie

1965